In advanced cancers, including breast, lung, and melanoma, leptomeningeal disease (LMD), a condition associated with rapid neurological deterioration, can develop. Treatment options remain limited, ...
Low-density lipoprotein receptor–related protein 1 overexpression as an identifier of brain metastasis and survival for patients with lung cancer. This is an ASCO Meeting Abstract from the 2026 ASCO ...
Plus Therapeutics Enters into License Agreement for Cerebrospinal Fluid Tumor Cell Enumeration Assay
As part of the agreement, Plus obtains a nonexclusive license and option for exclusivity for patients receiving CNS radiotherapy “Use of the CNSide assay has the potential to substantially improve the ...
In a study published in Nature, South Korean researchers led by Director Koh Gou Young of the Center for Vascular Research within the Institute for Basic Science (IBS) have uncovered a distinctive ...
Real-time liquid biopsy guided assessment of radiation response: Longitudinal circulating free DNA kinetics during precision radiotherapy across solid tumors from India. This is an ASCO Meeting ...
During the day, waste products such as lactic acid and worn-out proteins build up in the brain. When we sleep at night, waves ...
CHICAGO -- Intracerebroventricular (ICV) delivery of bivalent CAR T-cells targeting EGFR and IL13Rα2 was feasible and appeared safe in patients with recurrent glioblastoma (GBM) in a phase I study ...
Hosted on MSN
Staff at new data center powered by human brain cells need to swap out cerebrospinal fluid every day
A grisly detail about a new data center powered by human neurons: technicians have to constantly replenish the brainy computers’ cerebrospinal fluid. “We remove the fluid every 24 hours,” Hong Weng ...
Cerebrospinal fluid, or CSF, is a clear, colorless liquid that plays a crucial role in maintaining the health and function of your central nervous system. It cushions the brain and spinal cord, ...
Plus Therapeutics Enters into License Agreement for Cerebrospinal Fluid Tumor Cell Enumeration Assay
AUSTIN, Texas, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results